Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort study.
Ya-Chao TaoRong DengMeng-Lan WangDuo-Duo LvMan YuanYong-Hong WangEn-Qiang ChenHong TangPublished in: Virology journal (2018)
SOF-based regimens are highly effective in viral clearance and fibrosis remission for Chinese patients with HCV-GT3 infection. If available, SOF/VEL should be first considered.